{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:23:37Z","timestamp":1785252217528,"version":"3.55.0"},"reference-count":26,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","award":["3400798"],"award-info":[{"award-number":["3400798"]}],"id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRR"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Henoch-Sch\u00f6nlein purpura (IgA vasculitis) is the most common childhood\nvasculitis, one of its complications is renal involvement. However, several treatment regimens\nhave been proposed to improve renal function in the long term, but which drug regimen can\nbe most effective is still controversial.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>This study was a systematic review. In order to find evidence related to the purpose of\nthis study, databases including Google Scholar, Web of Science, ProQuest and Medline via\nPubMed, and Scopus were searched with the appropriate keywords. QUADAS-2 (a Quality Assessment\ntools for Diagnostic Accuracy Studies) checklist was also used to evaluate the quality of\nstudies. Based on the keywords used in reviewing the information sources of scientific articles, in\nthe first stage, 86 studies were included in the review. Taking into account characteristics such as\nlack of homogeneity with the objectives of the present study, finally, 11 studies were selected for\nanalysis and final evaluation.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>A total of 11 studies, including 722 patients in the age range of 5.5 to 9.9 years with HSP\nwere included in the study. The follow-up period of the patients varied from 6 months to 16 years\nin terms of examining the treatment process. In terms of study type, 7 studies were conducted as\nprospective or retrospective (non-interventional) cohorts and 4 studies as randomized clinical trials.\nThe treatment regimen of injectable methylprednisolone followed by oral prednisolone resulted in\na long-term recovery of 79.2% (95% confidence interval between 0.66% and 88.2%); however, the\nneed for additional immunosuppressive in two studies was mentioned as 38% and 46.1%, respectively.\nIn the therapeutic regimen of oral methylprednisolone alone, a significant improvement in\nlong-term renal function was achieved in comparison with placebo. Administration of injectable\nmethylprednisolone followed by cyclosporine A had the highest effectiveness in terms of improving\nrenal function in the long term.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Regimes based on the administration of prednisolone (either oral or injectable, either\nas a single drug or as a combination) lead to long-term improvement of renal function in patients\nwith HSP, but the use of other immunosuppressive drugs such as cyclosporine A, of course, with\noptimizing the drug dose can lead to a significant improvement in the clinical performance.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573397119666230825163008","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T04:31:50Z","timestamp":1693197110000},"page":"57-64","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of Different Treatment Regimens for Long-term Improvement\nof Renal Function in Patients with Henoch-Sch\u00f6nlein Purpura: A\nSystematic Review"],"prefix":"10.2174","volume":"20","author":[{"given":"Razieh","family":"Reicy","sequence":"first","affiliation":[{"name":"Pediatric resident, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Jari","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology,\nImam Hossein Children,s Hospital, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1007\/s00467-011-1919-5","volume":"26","author":"Jauhola O.","year":"2011","unstructured":"Jauhola O.; Ronkainen J.; Autio-Harmainen H.; Koskimies O.; Ala-Houhala M.; Arikoski P.; H\u00f6ltt\u00e4 T.; Jahnukainen T.; Rajantie J.; \u00d6rm\u00e4l\u00e4 T.; Nuutinen M.; Cyclosporine A vs. methylprednisolone for Henoch\u2013Sch\u00f6nlein nephritis: A randomized trial. Pediatr Nephrol 2011,26(12),2159-2166","journal-title":"Pediatr Nephrol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jpeds.2006.03.024","volume":"149","author":"Ronkainen J.","year":"2006","unstructured":"Ronkainen J.; Koskimies O.; Ala-Houhala M.; Antikainen M.; Merenmies J.; Rajantie J.; \u00d6rm\u00e4l\u00e4 T.; Turtinen J.; Nuutinen M.; Early prednisone therapy in Henoch-Sch\u00f6nlein purpura: A randomized, double-blind, placebo-controlled trial. J Pediatr 2006,149(2),241-247","journal-title":"J Pediatr"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"CD005128","DOI":"10.1002\/14651858.CD005128.pub3","volume":"2015","author":"Hahn D.","year":"2015","unstructured":"Hahn D.; Hodson E.M.; Willis N.S.; Craig J.C.; Interventions for preventing and treating kidney disease in Henoch-Sch\u00f6nlein Purpura (HSP). Cochrane Libr 2015,2015(8),CD005128","journal-title":"Cochrane Libr"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00467-011-2057-9","volume":"27","author":"Du Y.","year":"2012","unstructured":"Du Y.; Hou L.; Zhao C.; Han M.; Wu Y.; Treatment of children with Henoch-Sch\u00f6nlein purpura nephritis with mycophenolate mofetil. Pediatr Nephrol 2012,27(5),765-771","journal-title":"Pediatr Nephrol"},{"key":"ref=5","first-page":"184","volume":"14","author":"Xiong J-C.","year":"2014","unstructured":"Xiong J-C.; Tian M.; Efficacy and safety of mycophenolate mofetil for Henoch-Schonlein purpura nephritis: A systematic review. Chin J Evidence-Based Med 2014,14,184-190","journal-title":"Chin J Evidence-Based Med"},{"key":"ref=6","first-page":"220","volume":"71","author":"Bech A.P.","year":"2013","unstructured":"Bech A.P.; Reichert L.J.; Cohen Tervaert J.W.; Dapsone for the treatment of chronic IgA vasculitis (Henoch-Schonlein). Neth J Med 2013,71(4),220-221","journal-title":"Neth J Med"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.arcped.2011.08.011","volume":"18","author":"Mazille N.","year":"2011","unstructured":"Mazille N.; Lipsker D.; Fischbach M.; Dapsone treatment of chronic cutaneous forms of rheumatoid purpura: About 3 cases. Arch Pediatr 2011,18(11),1201-1204","journal-title":"Arch Pediatr"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1093\/ndt\/gfr137","volume":"26","author":"Pillebout E.","year":"2011","unstructured":"Pillebout E.; Rocha F.; Fardet L.; Rybojad M.; Verine J.; Glotz D.; Successful outcome using rituximab as the only immunomodulation in Henoch-Schonlein purpura: Case report. Nephrol Dial Transplant 2011,26(6),2044-2046","journal-title":"Nephrol Dial Transplant"},{"key":"ref=9","first-page":"27","author":"Bellan M.","year":"2015","unstructured":"Bellan M.; Pirisi M.; Sainaghi P.P.; Long-term remission of corticosteroid- and cyclophosphamide-resistant HenochSchonlein purpura with rituximab. Scand J Rheumatol 2015,27","journal-title":"Scand J Rheumatol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/619218","volume":"2014","author":"Pindi S.T.","year":"2014","unstructured":"Pindi S.T.; Michot J.M.; Snanoudj R.; Dollat M.; Est\u00e8ve E.; Marie B.; Taoufik Y.; Delfraissy J.F.; Lazure T.; Lambotte O.; Successful outcome of a corticodependent henoch-sch\u00f6nlein purpura adult with rituximab. Case Rep Med 2014,2014,1-4","journal-title":"Case Rep Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/ki.2010.150","volume":"78","author":"Pillebout E.","year":"2010","unstructured":"Pillebout E.; Alberti C.; Guillevin L.; Ouslimani A.; Thervet E.; Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Sch\u00f6nlein Purpura. Kidney Int the CESAR study group2010,78(5),495-502","journal-title":"Kidney Int"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5387\/fms.59.15","volume":"59","author":"Kawasaki Y.","year":"2013","unstructured":"Kawasaki Y.; Ono A.; Ohara S.; Suzuki Y.; Suyama K.; Suzuki J.; Hosoya M.; Henoch-Schonlein purpura nephritis in childhood: Pathogenesis, prognostic factors and treatment. Fukushima J Med Sci 2013,59(1),15-26","journal-title":"Fukushima J Med Sci"},{"key":"ref=13","first-page":"14060","volume":"8","author":"Yan M.","year":"2015","unstructured":"Yan M.; Wang Z.; Niu N.; Zhao J.; Peng J.; Relationship between chronic tonsillitis and Henoch-Schonlein purpura. Int J Clin Exp Med 2015,8(8),14060-14064","journal-title":"Int J Clin Exp Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/BOR.0000000000000236","volume":"28","author":"Barut K.","year":"2016","unstructured":"Barut K.; Sahin S.; Kasapcopur O.; Pediatric vasculitis. Curr Opin Rheumatol 2016,28(1),29-38","journal-title":"Curr Opin Rheumatol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","volume":"372","author":"Page M.J.","year":"2021","unstructured":"Page M.J.; Moher D.; Bossuyt P.M.; Boutron I.; Hoffmann T.C.; Mulrow C.D.; Shamseer L.; Tetzlaff J.M.; Akl E.A.; Brennan S.E.; Chou R.; Glanville J.; Grimshaw J.M.; Hr\u00f3bjartsson A.; Lalu M.M.; Li T.; Loder E.W.; Mayo-Wilson E.; McDonald S.; McGuinness L.A.; Stewart L.A.; Thomas J.; Tricco A.C.; Welch V.A.; Whiting P.; McKenzie J.E.; PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews. BMJ 2021,372(160),n160","journal-title":"BMJ"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/jebm.12141","volume":"8","author":"Zeng X.","year":"2015","unstructured":"Zeng X.; Zhang Y.; Kwong J.S.W.; Zhang C.; Li S.; Sun F.; Niu Y.; Du L.; The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: A systematic review. J Evid Based Med 2015,8(1),2-10","journal-title":"J Evid Based Med"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00296-010-1507-1","volume":"31","author":"Shin J.I.","year":"2011","unstructured":"Shin J.I.; Lee S.J.; Lee J.S.; Kim K.H.; Intravenous dexamethasone followed by oral prednisolone versus oral prednisolone in the treatment of childhood Henoch-Sch\u00f6nlein purpura. Rheumatol Int 2011,31(11),1429-1432","journal-title":"Rheumatol Int"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s00467-019-04238-2","volume":"34","author":"Koskela M.","year":"2019","unstructured":"Koskela M.; Jahnukainen T.; End\u00e9n K.; Arikoski P.; Kataja J.; Nuutinen M.; Ylinen E.; Methylprednisolone or cyclosporine a in the treatment of Henoch-Sch\u00f6nlein nephritis: A nationwide study. Pediatr Nephrol 2019,34(8),1447-1456","journal-title":"Pediatr Nephrol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1741-7015-2-7","volume":"2","author":"Huber A.M.","year":"2004","unstructured":"Huber A.M.; King J.; McLaine P.; Klassen T.; Pothos M.; A randomized, placebo-controlled trial of prednisone in early Henoch Sch\u00f6nlein Purpura. BMC Med 2004,2,2-7","journal-title":"BMC Med"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000046235","volume":"21","author":"Flynn J.T.","year":"2001","unstructured":"Flynn J.T.; Smoyer W.E.; Bunchman T.E.; Kershaw D.B.; Sedman A.B.; Treatment of Henoch-Sch\u00f6nlein Purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide. Am J Nephrol 2001,21(2),128-133","journal-title":"Am J Nephrol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s004670050446","volume":"12","author":"Niaudet P.","year":"1998","unstructured":"Niaudet P.; Habib R.; Methylprednisolone pulse therapy in the treatment of severe forms of Sch\u00f6nlein-Henoch purpura nephritis. Pediatr Nephrol 1998,12(3),238-243","journal-title":"Pediatr Nephrol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/BF01958961","volume":"151","author":"Mollica F.","year":"1992","unstructured":"Mollica F.; LiVolti S.; Garozzo R.; Russo G.; Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura. Eur J Pediatr 1992,151(2),140-144","journal-title":"Eur J Pediatr"},{"key":"ref=23","first-page":"1055","volume":"31","author":"Hisano S.","year":"1989","unstructured":"Hisano S.; Hatae K.; Yamane I.; Uragoh K.; Ueda K.; High-dose methylprednisolone therapy for nephrotic syndrome in Henoch-Schoenlein nephritis. Nippon Jinzo Gakkai Shi 1989,31(10),1055-1060","journal-title":"Nippon Jinzo Gakkai Shi"},{"key":"ref=24","first-page":"145","volume":"44","author":"Buchanec J.","year":"1989","unstructured":"Buchanec J.; Galanda V.; Bel\u00e1kov\u00e1 S.; Min\u00e1rik M.; Zibolen M.; The effect of prednisone in the development of nephropathy in Schoenlein-Henoch purpura. Cesk Pediatr 1989,44(3),145-146","journal-title":"Cesk Pediatr"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S0272-6386(81)80021-2","volume":"1","author":"Rose G.M.","year":"1981","unstructured":"Rose G.M.; Cole B.R.; Robson A.M.; The treatment of severe glomerulopathies in children using high dose intravenous methylprednisolone pulses. Am J Kidney Dis 1981,1(3),148-156","journal-title":"Am J Kidney Dis"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s10067-017-3972-3","volume":"37","author":"Buscatti I.M.","year":"2018","unstructured":"Buscatti I.M.; Casella B.B.; Aikawa N.E.; Watanabe A.; Farhat S.C.L.; Campos L.M.A.; Silva C.A.; Henoch-Sch\u00f6nlein purpura nephritis: Initial risk factors and outcomes in a Latin American tertiary center. Clin Rheumatol 2018,37(5),1319-1324","journal-title":"Clin Rheumatol"}],"container-title":["Current Rheumatology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573397119666230825163008","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/220400\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573397119666230825163008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T11:33:08Z","timestamp":1706182388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/220400\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573397119666230825163008","relation":{},"ISSN":["1573-3971"],"issn-type":[{"value":"1573-3971","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-02-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}